Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma

Clinical trial NCT02208362 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02208362
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Glioblastoma Recurrent Malignant Glioma Recurrent WHO Grade II Glioma Recurrent WHO Grade III Glioma Refractory Glioblastoma Refractory Malignant Glioma Refractory WHO Grade II Glioma Refractory WHO Grade III Glioma

Start date: 2015-05-18
Primary completion: 2021-02-08
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.